Literature DB >> 19357177

Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney.

Hyun Ju Kim1, Hamid Moradi, Jun Yuan, Keith Norris, Nosratola D Vaziri.   

Abstract

A significant reduction of renal mass results in proteinuria, glomerulosclerosis, and tubulointerstitial injury, culminating in end-stage chronic renal failure (CRF). The accumulation of lipids in the kidney can cause renal disease. Uptake of oxidized lipoproteins via scavenger receptors, reabsorption of filtered protein-bound lipids via the megalin-cubilin complex, and increased glucose load per nephron can promote lipid accumulation in glomerular, tubular, and interstitial cells in CRF. Cellular lipid homeostasis is regulated by lipid influx, synthesis, catabolism, and efflux. We examined lipid-regulatory factors in the remnant kidney of rats 11 wk after nephrectomy (CRF) or sham operation. CRF resulted in azotemia, proteinuria, lipid accumulation in the kidney, upregulation of megalin, cubilin, mediators of lipid influx (scavenger receptor class A and lectin-like oxidized receptor-1), lipid efflux (liver X receptor alpha/beta and ATP-binding cassette transporter), and fatty acid biosynthesis (carbohydrate-response element binding protein, fatty acid synthase, and acetyl-CoA carboxylase). However, factors involved in cholesterol biosynthesis (sterol regulatory element binding protein, 3-hydroxy-3-methylglutaryl coenzyme A reductase, SCAP, Insig-1, and Insig-2) and fatty acid oxidation (peroxisome proliferator-activated receptor, acyl-CoA oxidase, and liver-type fatty acid binding protein) were reduced in the remnant kidney. Thus CRF results in heavy lipid accumulation in the remnant kidney, which is mediated by upregulation of pathways involved in tubular reabsorption of filtered protein-bound lipids, influx of oxidized lipoproteins and synthesis of fatty acids, and downregulation of pathways involved in fatty acid catabolism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19357177      PMCID: PMC2692452          DOI: 10.1152/ajprenal.90761.2008

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  60 in total

1.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

Review 2.  The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor.

Authors:  M S Brown; J L Goldstein
Journal:  Cell       Date:  1997-05-02       Impact factor: 41.582

Review 3.  A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood.

Authors:  M S Brown; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

4.  Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes.

Authors:  Zhuowei Wang; Tao Jiang; Jinping Li; Gregory Proctor; James L McManaman; Scott Lucia; Streamson Chua; Moshe Levi
Journal:  Diabetes       Date:  2005-08       Impact factor: 9.461

5.  Hepatic HDL receptor, SR-B1 and Apo A-I expression in chronic renal failure.

Authors:  N D Vaziri; G Deng; K Liang
Journal:  Nephrol Dial Transplant       Date:  1999-06       Impact factor: 5.992

6.  Activation of transcription factor NF-kappa B in experimental glomerulonephritis in rats.

Authors:  H Sakurai; Y Hisada; M Ueno; M Sugiura; K Kawashima; T Sugita
Journal:  Biochim Biophys Acta       Date:  1996-06-07

7.  Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions.

Authors:  H Kataoka; N Kume; S Miyamoto; M Minami; H Moriwaki; T Murase; T Sawamura; T Masaki; N Hashimoto; T Kita
Journal:  Circulation       Date:  1999-06-22       Impact factor: 29.690

8.  Calorie restriction modulates renal expression of sterol regulatory element binding proteins, lipid accumulation, and age-related renal disease.

Authors:  Tao Jiang; Scott E Liebman; M Scott Lucia; Carrie L Phillips; Moshe Levi
Journal:  J Am Soc Nephrol       Date:  2005-06-08       Impact factor: 10.121

Review 9.  The role of the kidney in lipid metabolism.

Authors:  Søren K Moestrup; Lars Bo Nielsen
Journal:  Curr Opin Lipidol       Date:  2005-06       Impact factor: 4.776

10.  Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription.

Authors:  Seiji Ishii; Katsumi Iizuka; Bonnie C Miller; Kosaku Uyeda
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-20       Impact factor: 11.205

View more
  48 in total

1.  Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease.

Authors:  Nosratola D Vaziri; Kaveh Navab; Pavan Gollapudi; Hamid Moradi; Madeleine V Pahl; Cyril H Barton; Alan M Fogelman; Mohamad Navab
Journal:  J Natl Med Assoc       Date:  2011-06       Impact factor: 1.798

2.  Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression.

Authors:  Nosratola D Vaziri; Jun Yuan; Zhenmin Ni; Susanne B Nicholas; Keith C Norris
Journal:  Clin Exp Nephrol       Date:  2011-10-19       Impact factor: 2.801

Review 3.  Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease.

Authors:  Nosratola D Vaziri
Journal:  Clin Exp Nephrol       Date:  2013-08-24       Impact factor: 2.801

4.  Differential network enrichment analysis reveals novel lipid pathways in chronic kidney disease.

Authors:  Jing Ma; Alla Karnovsky; Farsad Afshinnia; Janis Wigginton; Daniel J Rader; Loki Natarajan; Kumar Sharma; Anna C Porter; Mahboob Rahman; Jiang He; Lee Hamm; Tariq Shafi; Debbie Gipson; Crystal Gadegbeku; Harold Feldman; George Michailidis; Subramaniam Pennathur
Journal:  Bioinformatics       Date:  2019-09-15       Impact factor: 6.937

Review 5.  Renal interstitial fibrosis: mechanisms and evaluation.

Authors:  Alton B Farris; Robert B Colvin
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-05       Impact factor: 2.894

Review 6.  Role of triglyceride-rich lipoproteins in diabetic nephropathy.

Authors:  John C Rutledge; Kit F Ng; Hnin H Aung; Dennis W Wilson
Journal:  Nat Rev Nephrol       Date:  2010-05-04       Impact factor: 28.314

Review 7.  Renal lipid metabolism and lipotoxicity.

Authors:  Ion Alexandru Bobulescu
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-07       Impact factor: 2.894

8.  Sterol-O-acyltransferase-1 has a role in kidney disease associated with diabetes and Alport syndrome.

Authors:  Xiaochen Liu; Gloria Michelle Ducasa; Shamroop Kumar Mallela; Jin-Ju Kim; Judith Molina; Alla Mitrofanova; Sydney Symone Wilbon; Mengyuan Ge; Antonio Fontanella; Christopher Pedigo; Javier Varona Santos; Robert G Nelson; Yelena Drexler; Gabriel Contreras; Hassan Al-Ali; Sandra Merscher; Alessia Fornoni
Journal:  Kidney Int       Date:  2020-07-30       Impact factor: 10.612

9.  High-calorie diet partially ameliorates dysregulation of intrarenal lipid metabolism in remnant kidney.

Authors:  Hyun Ju Kim; Jun Yuan; Keith Norris; Nosratola D Vaziri
Journal:  J Nutr Biochem       Date:  2009-12-01       Impact factor: 6.048

10.  The role of renin angiotensin system inhibition in kidney repair.

Authors:  Irene M van der Meer; Paolo Cravedi; Giuseppe Remuzzi
Journal:  Fibrogenesis Tissue Repair       Date:  2010-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.